Recent advances in the etiopathogenesis of inflammatory bowel disease: the role of omics
E Stylianou - Molecular diagnosis & therapy, 2018 - Springer
Omics technology presents an exciting and timely opportunity to improve our understanding
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics
E Stylianou - Molecular Diagnosis & Therapy, 2018 - search.proquest.com
Omics technology presents an exciting and timely opportunity to improve our understanding
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
E Stylianou - Molecular Diagnosis & Therapy, 2018 - europepmc.org
Omics technology presents an exciting and timely opportunity to improve our understanding
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics
E Stylianou - Molecular diagnosis & therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Omics technology presents an exciting and timely opportunity to improve our understanding
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …
of the molecular etiology and pathogenesis of the group of chronic, heterogeneous …